UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) July 23, 2003
MILESTONE SCIENTIFIC INC.
(Exact name of Registrant as specified in its charter)
Delaware 13-3545623
(State or other jurisdiction of (Commission File (IRS Employer
incorporation) Number) Identification No.)
220 South Orange Avenue, Livingston Corporate Park, Livingston, NJ 07039
(Address of Principal Executive Office) (Zip Code)
Registrant's telephone number (973) 535-2717
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
Item 5: Other Events and Required FD Disclosure
(a) On July 21, 2003, the Registrant issued a press release announcing
the results of its reconvened Annual Meeting of Stockholders. A copy
of the Registrant's press release is attached as Exhibit 99.1 to
this Current Report.
(b) On July 22, 2003, the Registrant issued a press release announcing
that the United States Patent Office has granted the Registrant a
Notice of Allowance for broad patent protection on automated rate
control technology, used in conjunction with the computer controlled
local anesthetic delivery systems manufactured and distributed by
the Registrant. A copy of the Registrant's press release is attached
as Exhibit 99.2 to this Current Report.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Current Report on Form 8-K to be signed on its
behalf by the undersigned, hereunto duly authorized.
Milestone Scientific Inc.
by: /s/ Leonard Osser
--------------------------------------
Leonard Osser, Chief Executive Officer
Dated: July 23, 2003